Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Dow
Queensland Health
Accenture
Healthtrust
Deloitte
McKinsey
Fish and Richardson
Fuji

Generated: January 16, 2018

DrugPatentWatch Database Preview

Taliglucerase alfa - Generic Drug Details

« Back to Dashboard

What are the generic sources for taliglucerase alfa and what is the scope of taliglucerase alfa freedom to operate?

Taliglucerase alfa
is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Taliglucerase alfa has seventy-eight patent family members in twenty-five countries.

One supplier is listed for this compound.
Summary for taliglucerase alfa
International Patents:78
US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Clinical Trials: 5
Drug Prices:see low prices
DailyMed Link:taliglucerase alfa at DailyMed
Pharmacology for taliglucerase alfa

US Patents and Regulatory Information for taliglucerase alfa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer ELELYSO taliglucerase alfa POWDER;IV (INFUSION) 022458-001 May 1, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer ELELYSO taliglucerase alfa POWDER;IV (INFUSION) 022458-001 May 1, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer ELELYSO taliglucerase alfa POWDER;IV (INFUSION) 022458-001 May 1, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Pfizer ELELYSO taliglucerase alfa POWDER;IV (INFUSION) 022458-001 May 1, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer ELELYSO taliglucerase alfa POWDER;IV (INFUSION) 022458-001 May 1, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for taliglucerase alfa

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,391,638 Cell/tissue culturing device and method ➤ Subscribe
7,951,557 Human lysosomal proteins from plant cell culture ➤ Subscribe
9,220,737 Plant cell culture expressing human lysosomal proteins and uses thereof ➤ Subscribe
8,449,876 Human lysosomal proteins from plant cell culture ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for taliglucerase alfa

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Daiichi Sankyo
Chinese Patent Office
UBS
Federal Trade Commission
Boehringer Ingelheim
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot